Benzinga All Access

Brian Esposito, CEO of Diamond Lake Minerals, Inc. (OTCMKTS: DLMI), was recently a guest on Benzinga’s All-Access. Diamond Lake Minerals, Inc. specializes in the development and support of digital assets and SEC-registered security tokens. The company’s goal is to responsibly innovate...

Dr. Vuong Trieu, CEO & Chairman of Oncotelic Therapeutics, Inc. was recently a guest on Benzinga’s All-Access. Oncotelic is a biotechnology company focused on developing RNA therapeutics for hard-to-treat cancers. The company has extensive experience in the field and its lead candidate OT...

Raymond Wang, CEO of Greenland Technologies Holding Corp. (NASDAQ: GTEC), was recently a guest on Benzinga’s All-Access. Greenland Technologies is a leading developer and manufacturer of electric industrial vehicles and drive train systems for material handling vehicles. The company has...

Vin Singh, Founder & CEO of BullFrog AI (NASDAQ: BFRG), was recently a guest on Benzinga’s All-Access. BullFrog is an artificial intelligence company that has developed AI technology it calls bfLEAP. The platform is designed to transform the field of precision medicine by applying...

Dean Skurka, CEO of WonderFi Technologies Inc (TSX: WNDR) (OTCQB: WONDF) (WKN: A3C166), was recently interviewed by Benzinga. WonderFi operates digital asset platforms trusted by over 1.6 million Canadians. WonderFi's Bitbuy, Coinsquare and CoinSmart cryptocurrency trading platforms provide...

Martha Stokes, CMT, Co-founder & CEO of TechniTrader, was recently a guest on Benzinga’s All-Access. TechniTrader is an educational company focused on teaching traders and investors a complete process for trading or investing in the stock market and other financial markets. Founded in...

J. Clay Sell, CEO of X-Energy Reactor Company, was recently a guest on Benzinga’s All-Access. X-energy is a leading developer of small modular nuclear reactors and fuel technology for clean energy generation. The company says it is bringing a new, completely safe and reliable energy source to...

Trent Ward, CEO of Interactive Strength doing business as FORME (NASDAQ: TRNR), was a guest recently on Benzinga’s All-Access. FORME is a digital fitness service that combines award-winning smart home gyms with 1:1 personal training from real people to deliver an immersive experience and...

Wa’el Hashad, CEO of Longeveron (NASDAQ: LGVN), was a guest recently on Benzinga’s All-Access. Longeveron is a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions. Its lead investigational product is Lomecel-B™,...

Claire Stawnyczy, CEO of Lophos Pharmaceuticals (CSE: MESC), was a guest recently on Benzinga’s All-Access. Lophos Pharmaceuticals is a bioscience company involved in the research and development of mescaline and peyote medicines for indications from mental health to alcohol use disorder. The...

Raymond Wang, CEO of Greenland Technologies Holdings (NASDAQ: GTEC), was recently a guest on Benzinga’s All-Access. Greenland is a leading developer and manufacturer of electric industrial vehicles and drive train systems for material handling vehicles. The company has captured the lion's...

David Meniane, CEO of CarParts.com (NASDAQ: PRTS), was a guest recently on a special edition of All-Access hosted by Benzinga’s own, Luke Jacobi. CarParts.com is an e-commerce company offering a factory-to-consumer online shopping experience for everyday drivers. The company has been in...

Martha Stokes, CMT, Co-founder & CEO of TechniTrader was a guest recently on Benzinga’s All-Access. TechniTrader is an educational company focused on teaching traders and investors a complete process for trading or investing in the stock market and other financial markets. Founded in 1998...

Thomas Meyer, CEO of Altamira Therapeutics (NASDAQ: CYTO), was recently a guest on Benzinga’s All-Access. Altamira develops RNA-based therapeutics for extrahepatic targets. The company also has legacy programs in allergy and viral infections and inner ear disorders, which it intends to...

Dr. Jim Woody, CEO of 180 Life Sciences Corp. (NASDAQ: ATNF), was recently a guest on Benzinga’s All-Access. 180 Life Sciences is a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain. The company...